| Financial Year |
March 31 2023 |
| Monetary Funds |
1,934,100,759.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,127,485.68 |
| Accounts Receivable |
1,367,334,975.76 |
| Advances to Suppliers |
245,076,141.08 |
| Other Receivables |
24,513,930.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,726,827,232.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
54,605,865.01 |
| Total Current Assets |
6,712,148,788.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
40,453,572.74 |
| Investment Properties |
-- |
| Fixed Assetes |
2,813,149,088.98 |
| Under-construction Projects |
232,108,753.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
393,092,948.15 |
| R&D expenses |
10,886,683.62 |
| Goodwill |
636,803,814.85 |
| Long-Term Deferred and Prepaid Expenses |
48,703,945.52 |
| Deferred Income Tax Assets |
61,113,457.98 |
| Other Non-Current Assets |
10,332,547.01 |
| Sub-Total of Non-Current Assets |
4,385,228,464.92 |
| Total Assets |
11,097,377,253.86 |
| Short-Term Loans |
292,135,619.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,518,517,953.10 |
| Accounts Payable |
1,365,312,831.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
162,952,710.94 |
| Taxes Payable |
31,883,917.72 |
| Interest Payable |
-- |
| Dividend Payable |
60,446,879.29 |
| Other payables |
147,136,777.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
54,983,359.89 |
| Sub-Total of Current Liabilities |
3,995,872,092.32 |
| Long-term Loans |
650,536,250.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
53,515,274.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
43,591.83 |
| Deferred Income Tax Liabilities |
13,446,179.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
756,028,331.82 |
| Total Liabilities |
4,751,900,424.14 |
| Paid-In Capital(Or Share Stock) |
1,026,008,097.00 |
| Capital Surplus |
2,762,426,325.39 |
| Surplus Reserve |
383,332,136.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
857,295,731.72 |
| Minority Stockholder's Interest |
1,316,360,951.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,029,115,878.61 |
| Owner's Equity（Stockholder's Equity） |
6,345,476,829.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,097,377,253.86 |
